High Tide Inc. Acquires Majority Stake in Remexian Pharma GmbH, Expands into German Market
High Tide Inc. has acquired a 51% stake in Remexian Pharma GmbH, marking its entry into the German medical cannabis market. This strategic move aims to capitalize on the growing demand for medical cannabis in Germany and reflects High Tide's commitment to expanding its international presence. The announcement underscores a significant step in the company's growth strategy.
High Tide Inc. has announced its acquisition of a majority stake in Remexian Pharma GmbH, marking its entry into the German medical cannabis market. The transaction involves High Tide acquiring 51% of Remexian Pharma GmbH, a move that positions the company to tap into the rapidly growing demand for medical cannabis in Germany. This strategic acquisition highlights High Tide’s commitment to expanding its international footprint and diversifying its market presence. The announcement was made by High Tide, signifying a significant step in the company’s growth strategy. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. High Tide Inc. published the original content used to generate this news brief on August 15, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
